Arcellx, Inc. (NASDAQ: ACLX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $70.00 price target on the stock.
Arcellx, Inc. (NASDAQ: ACLX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Arcellx, Inc. (NASDAQ: ACLX) had its price target raised by analysts at Stifel Nicolaus from $82.00 to $83.00. They now have a "buy" rating on the stock.
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy [Yahoo! Finance]
Arcellx, Inc. (NASDAQ: ACLX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $85.00 price target on the stock.